Unify Financial Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Unify Financial Advisors's RPRX Position: Q3 2026 in Review
Unify Financial Advisors reduced its Royalty Pharma (RPRX) stake by 1.2% in Q3 2026, selling an estimated $6.02K and leaving 8,700 shares worth $508K. The position accounts for 0.47% of the portfolio, ranked #55.
Unify Financial Advisors first reported a position in RPRX in Q4 2025 and has held it in 4 quarters since. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Unify Financial Advisors held 8,700 shares of Royalty Pharma worth $508K as of Q3 2026.
- Unify Financial Advisors sold 102 Royalty Pharma shares in Q3 2026, an estimated $6.02K.
- Royalty Pharma made up 0.47% of Unify Financial Advisors's portfolio in Q3 2026, its #55 holding.
- Unify Financial Advisors first reported a position in Royalty Pharma in Q4 2025 and has held it in 4 quarters since.
- 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Unify Financial Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.